Stock data
Dyne Therapeutics, Inc. (DYN)
Dyne Therapeutics, Inc. (DYN) reported net income of -US$446.21M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$468.18M | -US$446.21M | — |
| 2024 | — | — | -US$343.89M | -US$317.42M | — |
| 2023 | — | — | -US$242.16M | -US$235.94M | — |
| 2022 | — | — | -US$170.96M | -US$168.10M | — |
| 2021 | — | — | -US$150.03M | -US$149.29M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$178.56M | — |
| 2026-03-31 | — | -US$120.85M | — |
| 2025-12-31 | — | -US$111.95M | — |
| 2025-09-30 | — | -US$108.04M | — |
| 2025-06-30 | — | -US$110.86M | — |
| 2025-03-31 | — | -US$115.36M | — |
| 2024-12-31 | — | -US$89.54M | — |
| 2024-09-30 | — | -US$97.12M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.